Filing Details

Accession Number:
0001250853-14-000068
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-04-09 20:44:04
Reporting Period:
2014-01-23
Filing Date:
2014-04-09
Accepted Time:
2014-04-09 20:44:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1390478 Galena Biopharma Inc. GALE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197482 A Steven Kriegsman C/O Galena Biopharma, Inc.
4640 S.w. Macadam Avenue, Suite 270
Portland OR 97239
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-01-23 100,000 $1.18 105,000 No 4 M Direct
Common Stock Acquisiton 2014-01-23 50,000 $2.31 155,000 No 4 M Direct
Common Stock Disposition 2014-01-23 150,000 $5.92 5,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-01-23 100,000 $0.00 100,000 $1.18
Common Stock Stock Option (right to buy) Disposition 2014-01-23 50,000 $0.00 50,000 $2.31
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-03-24 No 4 M Direct
0 2021-01-13 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.8845 to $5.9722 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. The option vested in equal quarterly installments of 25,000 shares on each of June 25, 2011, September 25, 2011, December 25, 2011 and March 25, 2012.
  3. The option vested in equal quarterly installments of 12,500 shares on each of March 31, 2011, June 30, 2011, September 30, 2011 and December 31, 2011.